Jonas Salk in 2007, 12 years after Jonas Salk's death in 1995. Although many advances have been made in treating AIDS, "the world still waited for the miracle vaccine the conqueror of polio had sought", wrote historian Alan Axelrod. In 1966, "The New York Times" referred to him as the "Father of Biophilosophy." According to "Times" journalist and author Howard Taubman, "he never forgets ... there is a vast amount of darkness for man to penetrate. As a biologist, he believes that his science is on the frontier of tremendous new discoveries; and as a philosopher, he is convinced that humanists and
SAV001 a feasible option for an HIV vaccine. Indeed, Jonas Salk developed a therapeutic HIV vaccine in 1987, called Remune now being developed by Immune Response BioPharma, Inc., is based on the killed whole virus approach. Remune vaccine has completed over 25 clinical studies to date and showed a robust mechanism of action restoring white blood cell counts in CD4 & CD8 T cells by reducing viral load and increasing immunity. Also, a group of researchers and professionals in the field of HIV strongly advocates that the killed HIV approach must be taken to fight back the global HIV and AIDS